The Livingston Group, LLC Obo Innovative Vaccine Technologies
Consulting/lobbying firm
Based in DC
🤖
AI Overview
With $50K in lobbying spend across 9 quarterly filings, The Livingston Group, LLC Obo Innovative Vaccine Technologies is an active lobbying client. Their lobbying covers 1 issue area. Active from 2024 to 2025.
$50K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $40K |
| 2025 | $10K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Defense
- •FY2024 and FY2025 Defense Appropriations Act, RDT&E Title for vaccine product dev.
- •H>8774 and S 4921, FY2025 Defense Appropriations Act, RDT&E Title for vaccine product dev.
Related Analysis
Related Investigations
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.